Press Releases

 Filter by Provider

nLIGHT, Inc. (Nasdaq: LASR), a leading provider of high-power lasers for mission critical directed energy, optical sensing, and advanced manufacturing applications, today reported record financial results for the fourth quarter and full year 2025.

Semtech Corporation (Nasdaq: SMTC), a leading provider of high-performance semiconductor, Internet of Things (IoT) systems and cloud connectivity service solutions, today announced its participation in MWC26 Barcelona, taking place Mar. 2–5, 2026. Semtech will showcase its latest IoT innovations in its Executive Meeting Room 7B4Ex in Hall 7, where attendees can meet with experts across the company’s cellular IoT and LoRa technology portfolio.

Ulta Beauty, Inc. (NASDAQ: ULTA) today announced that its financial results for the fourth quarter and fiscal year 2025 will be released Thursday, March 12, 2026, after the market closes. The Company will host a webcast and conference call at 4:30 p.m. ET / 3:30 p.m. CT to discuss the financial results.

The Caliber family of automotive repair and service brands, including Caliber Collision and Caliber Auto Glass, today announced changes to its finance organization.

Airgain, Inc. (NASDAQ: AIRG), a leading provider of advanced wireless connectivity solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025.

48% Full-Year Revenue Growth and Strong Q4 Results

Dell Technologies (NYSE: DELL) announces financial results for its fiscal 2026 fourth quarter and full year ended January 30, 2026. The company also provides guidance for its fiscal 2027 first quarter and full year.

MP Materials Corp. (NYSE: MP) (“MP Materials” or the “Company”), today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Strategic Education, Inc. (Strategic Education) (NASDAQ: STRA) today announced financial results for the period ended December 31, 2025.

Block, Inc. (NYSE: XYZ) has posted its results for the fourth quarter of 2025 on the Financials section of its Investor Relations website at investors.block.xyz. Block will host a conference call and earnings webcast at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time today to discuss these financial results.

Fourth quarter and full year 2025 revenue exceeded guidance

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2025. Unless otherwise stated, all comparisons are for the fourth quarter and full year 2025 compared to the fourth quarter and full year 2024.

IRVINE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Shimmick Corporation (“Shimmick”) (Nasdaq: SHIM), a national leader in complex infrastructure solutions, today announced that the company will release its fourth quarter and full year 2025 financial results after market close on Thursday, March 12, 2025.

The Board of Directors of Belden Inc. (NYSE: BDC) today declared a quarterly dividend to holders of common stock of $0.05 per share payable on April 9, 2026, to shareholders of record as of March 12, 2026.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the fourth quarter and full year ended December 31, 2025.

SANTA CLARA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO) (“Company”, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and innovation, will release its financial results for the fourth quarter ended December 31, 2025, after the market close on Thursday, March 12, 2026. The company will host a conference call at 5:00 p.m. Eastern time to discuss its fourth quarter and full year 2025 results and full year 2026 outlook.

CLINTON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Unity Bancorp, Inc. (NASDAQ: UNTY), parent company of Unity Bank, announced that its Board of Directors has declared a cash dividend of $0.16 per common share. Such dividend is payable on March 20, 2026, to shareholders of record as of March 6, 2026.

Fourth Quarter 2025Revenue was $570.0 Million, up 0.4 PercentNet Loss of $170.5 Million due to a $205.4 Million Non-Cash Goodwill Impairment and Related Tax Adjustment(Net Income of $22.8 Million or 4.0 Percent of Revenue Non-GAAP)Adjusted EBITDA was $62.2 Million or 10.9 Percent of Revenue

Contracted 522 critical IT MW totaling over $12.8 billion1 of revenue

Increased 2025 Revenue by 14% Year-over-Year to $748.3 Million, Driven by Global Growth in Social, CTV Measurement, and Programmatic Activation

EVERTEC, Inc. (NYSE: EVTC) (“Evertec” or the “Company”) today announced results for the fourth quarter and full year ended December 31, 2025.

2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased 37% over 2024

HOUSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that its Board of Directors approved a new one-year share repurchase program, under which the Company is authorized to repurchase up to 3,014,986 common shares, representing 10% of the current outstanding common shares of Epsilon, for an aggregate purchase price of not more than US $15.0 million, pursuant to a normal course issuer bid. The one-year period commenced on February 19, 2026. The program will end on February 18, 2027, unless the maximum amount of common shares is purchased before then or Epsilon provides earlier notice of termination. This program replaces the previous share repurchase program, which expired on February 11, 2026.

OXNARD, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”) a world leader in sourcing, producing, and distributing fresh Hass avocados, today announced it will release its financial results for the fiscal first quarter ended January 31, 2026 after the market closes on Thursday, March 12, 2026. The Company will host a conference call and webcast to discuss its financial results at 5:00 PM Eastern Time on the same day.

Build-A-Bear Workshop, Inc. (NYSE: BBW) today announced that the Company will report fourth-quarter fiscal 2025 results for the period ended January 31, 2026, on Thursday, March 12, 2026, before the opening of trading on the New York Stock Exchange. The Company will host its quarterly investor conference call to discuss the results at 9 a.m. ET on the same day.

Board of Directors Declared Total Dividends of $0.52 per Share for First Quarter 2026

Record full year 2025 revenue of $236.3 million increased 15% compared to prior yearOperating Cash flow improvement of $22 million in full year 2025Generated $10 million of free cash flow in the fourth quarter, the first quarter of positive free cash flow in Company history

PALSONIFY™ (Paltusotine) Net Product Revenue of $5.4 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December

Full year SaaS revenue of $319.2 million, representing 38% year-over-year growth, 36% on a constant currency basisFull year Total revenue of $419.5 million, representing 27% year-over-year growth, 25% on a constant currency basisTotal ARR of $416.8 million, representing 27% year-over-year growth, 26% adjusted for FX

GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2025.

MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Jefferson Capital, Inc. (NASDAQ: JCAP) (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, today announced that it will release financial results for the fourth quarter 2025 after the market close on Thursday, March 12, followed by a webcast at 5:00 pm Eastern Time that day to discuss the Company’s results.

SAN JOSE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that its management will present at the following upcoming financial community event:

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) --  Flutter Entertainment (NYSE:FLUT; LSE:FLTR), the world's leading online sports betting and iGaming operator, announces Q4 and full year 2025 results, and introduces 2026 guidance.

Initial Phase 1 data of zovegalisib in PIK3CA-driven vascular anomalies expected to be announced in first half of 2026

Company achieves record 7.5 million pounds of PureFive® production in Q4; appoints Donald Carpenter as CFO; progresses Gen-2 design showing path to costs below virgin polypropylene

Earnings Release Highlights

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced that members of its management team will participate in the following investor conferences:

Guides to record Q1 revenue of $185M - $200M, representing year-on-year growth of 57% at the midpoint of the range

Initiates Non-GAAP 30% Rule of 40 Target By the Fourth Quarter of 2027 Approximated Subscription Revenue Contribution for ≥$30K ARR Customers Grew 22% in 2025

REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025.

Samsung Electronics America, along with entrepreneurs Mark Cuban, Emma Grede and Allison Stransky, hosted the first-ever Samsung Solve for Tomorrow: AI in Action Lab in New York City, bringing together hundreds of students for a hands-on experience designed to turn curiosity about AI into real-world opportunity. Students from A. Philip Randolph Campus High School received education and career advice from Mark Cuban, Emma Grede and Samsung executives, and engaged in an immersive AI in Action Lab co-led by the Mark Cuban Foundation that encouraged students to confidently engage with emerging AI tools and Samsung technology.

Company surpassed $2 billion in GMV, accelerated active buyer growth, and exceeded 2025 financial guidance

Southfield, MI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (NYSE: SUI) (the “Company”), a real estate investment trust ("REIT") that owns and operates, or has an interest in, manufactured housing (“MH”) and recreational vehicle (“RV”) communities, today announced that Charles Young, Chief Executive Officer, will present at the 2026 Citi Global Property CEO Conference in Hollywood, Florida, on Monday, March 2, 2026, at 1:30 p.m. Eastern Standard Time.

Phoenix, AZ - The increasing demand for specialized services for children diagnosed with autism has led to a rise in the need for effective therapy options. In response to this growing need, Children’s Specialized ABA, a trusted provider of Applied Behavior Analysis (ABA) therapy, is expanding its services to Phoenix. This expansion aims to provide families with high-quality, individualized therapy that helps children thrive.

Positive results from the aleniglipron Phase 2 ACCESS programs in December 2025 demonstrated significant weight loss across all doses and up to 15.3% at 36 weeks

SBA Communications Corporation (Nasdaq: SBAC) ("SBA" or the "Company") today reported results for the quarter ended December 31, 2025.

OneSpan Inc. (NASDAQ: OSPN) today reported financial results for the fourth quarter and full year ended December 31, 2025.

Clipper Realty Inc. (NYSE: CLPR) (the “Company”), a leading owner and operator of multifamily residential and commercial properties in the New York metropolitan area, today announced financial and operating results for the three months ended December 31, 2025.

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to NGN-401, an investigational gene therapy in late-stage clinical development as a potential best-in-class treatment for Rett syndrome.

Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today reported its full-year 2025 financial results and provided business updates.